BioCentury
ARTICLE | Clinical News

Second-generation multiple-epitope AIDS vaccine: To begin a Phase I study

April 18, 1994 7:00 AM UTC

Lederle Praxis (American Cyanamid) Product: Second-generation multiple-epitope AIDS vaccine Indication: Treat AIDS Status: National Institute of Allergy and Infectious Diseases will begin within 3-5 w...